Rather, NB is characterized by genomic aberrations such as MYCN amplification, deletions of parts of chromosome 11q, 1p, gain of 2p and 17q and structural variants, e.g., in TERT, DLG2, and PTPRD [18, 25–28]. This evidence concerns the gene MYCN and neuroblastoma.